• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 10, 2024 at 06:32: PM
via Despite persistent supply hitches since Wegovy’s launch in 2021, Novo Nordisk has quickly garnered blockbuster sales in the newly untapped obesity market. And to hear Novo’s CEO Lars Fruergaard Jørgensen tell it, the company is "just getting going" in the field.

article source
 

<



Similar threads

cafead
JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals
Replies
0
Views
140
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage
Replies
0
Views
140
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
JPM24, Day 3: Gene editors take the stage to talk business development, germline edits
Replies
0
Views
141
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
JPM24: BioMarin&#039;s new CEO Hardy says top priority is expansion of dwarfism drug Voxzogo
Replies
0
Views
222
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
JPM24: After &#039;clearing the decks,&#039; Alkermes ready to roll as pure-play...
Replies
0
Views
109
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote